Structural Requirements for Cationic Lipid Mediated Phosphorothioate Oligonucleotides Delivery to Cells in Culture

References

• Altmann K.-H., Dean N. M., Fabbro D., Freier S. M., Geiger T., Haner R., Husken D., Martin P., Monia B. P., Muller M., Natt F., Nicklin P., Phillips J., Pieles U., Sasmor H., Moser H. E. Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals. Chimia 1996; 50: 168–176
   Web of Science ®Google Scholar
• Balboa M. A., Balsinde J., Winstead M. V., Tischfield J. A., Dennis E. A. Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J. Biol. Chem. 1996; 271: 32381–32384
   PubMed Web of Science ®Google Scholar
• Bennett C. F., Chiang M.-Y., Chan H., Shoemaker J. E. E., Mirabelli C. K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 1992; 41: 1023–1033
   PubMed Web of Science ®Google Scholar
• Bennett C. F., Chiang M.-Y., Chan H., Grimm S. Use of cationic lipids to enhance the biological activity of anti-sense oligonucleotides. J. Liposome Res. 1993; 3: 85–102
   Google Scholar
• Bennett C. F., Condon T., Grimm S., Chan H., Chiang M.-Y. Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides. J. Immunol. 1994; 152: 3530–3540
   PubMed Web of Science ®Google Scholar
• Bennett C. F., Zuckerman J. E., Kornbrust D., Sasmor H., Leeds J. M., Crooke S. T. Pharmacokinetics in mice of a [3H]-labeled phosphorothioate oligonucleotide formulated in the presence and absence of a cationic lipid. J. Control. Rel. 1996; 41: 121–130
   Web of Science ®Google Scholar
• Brigham K., Meyrick B., Christman B., Magnuson M., King G., Berry L. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. 1993; 298: 278–281
   Google Scholar
• Chang H., Epand R. M. The existence of a highly ordered phase in fully hydrated dilauroylphophatidylethanolamine. Biochim. Biophys. Acta 1983; 728: 319–326
   PubMed Web of Science ®Google Scholar
• Chiang M.-Y., Chan H., Zounes M. A., Freier S. M., Lima W. F., Bennett C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 1991; 266: 18162–18171
   PubMed Web of Science ®Google Scholar
• Colige A., Sokolov B. P., Nugent P., Baserga R., Prockop D. J. Use of antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells. Biochemistry 1993; 32: 7–11
   PubMed Web of Science ®Google Scholar
• Condon T. P., Bennett C. F. Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells. J. Biol. Chem. 1996; 271: 30398–30403
   PubMed Web of Science ®Google Scholar
• Cook P. D. Medicinal chemistry strategies for antisense research. Antisense Research and Applications, S. T. Crooke, B. Lebleu. CRC Press, Boca Raton 1993; 149–187
   Google Scholar
• Crooke S. T. Therapeutic applications of oligonucleotides. Ann. Rev. Pharmacol. Toxicol. 1992; 32: 329–376
   PubMed Web of Science ®Google Scholar
• Crooke S. T. Therapeutic Applications of Oligonucleotides. R. G. Landes Company, Austin 1995
   Google Scholar
• Crooke R. M., Graham M. J., Cooke M. E., Crooke S. T. In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. J. Pharm. Exp. Ther. 1995; 275: 462–473
   PubMed Web of Science ®Google Scholar
• Crooke S. T., Bennett C. F. Progress in antisense oligonucleotide therapeutics. Ann. Rev. Pharmacol. Toxicol. 1996; 36: 107–129
   PubMed Web of Science ®Google Scholar
• Cullis P. R., De Kruijff B. Lipid polymorphism and the functional role of lipids in biological membranes. Biochim. Biophys. Acta 1979; 559: 399–488
   PubMed Web of Science ®Google Scholar
• Dean N. M., McKay R., Condon T. P., Bennett C. F. Inhibition of protein kinase C-a expression in human A549 cells by antisense oligonucleotides inhibits induction of intracellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J. Biol. Chem. 1994; 269: 16416–16424
   PubMed Web of Science ®Google Scholar
• Duff J. L., Monia B. P., Berk B. C. Mitogen-Activated Protein (MAP) kinase is regulated by the MAP Kinase Phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J. Biol. Chem. 1995; 270: 7161–7166
   PubMedGoogle Scholar
• Duzgunes N., Goldstein J. A., Friend D. S., Feigner P. L. Fusion of liposomes containing a novel cationic lipid, N-[2,3-(dioeyloxy)propyl]-N,N,N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. Biochemistry 1989; 28: 9178–9184
   Google Scholar
• Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop J. P., Ringold G. M., Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 7413–7417
   PubMed Web of Science ®Google Scholar
• Felgner J. H., Kumar R., Sridhar C. N., Wheeler C. J., Tsai Y. J., Border R., Ramsey P., Martin M., Feigner P. L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 1994; 269: 2550–2561
   PubMed Web of Science ®Google Scholar
• Gagne J., Stamatatos L., Diacovo T., Hui S. W., Yeagle P. L., Silvius J. R. Physical properties and surface interactions of bilayer membranes containing N-methylated phosphatidylethanolamine. Biochemistry 1985; 24: 4400–4408
   PubMed Web of Science ®Google Scholar
• Gao W.-Y., Storm C., Egan W., Cheng Y.-C. Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol. Pharmacol. 1993; 43: 45–50
   PubMed Web of Science ®Google Scholar
• Gao X., Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 1991; 179: 280–285
   PubMed Web of Science ®Google Scholar
• Haller H., Dragun D., Miethke A., Park J. K., Weis A., Lippoldt A., Grab V., Luft F. C. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int. 1996; 50: 473–480
   PubMed Web of Science ®Google Scholar
• Hope M. J., Walker D. C., Cullis P. R. Calcium and pH induced fusion of small unilamellar vesicles consisting of phosphatidylethanolamine and negative charged phospholipids: a freeze-fracture study. Biochem. Biophys. Res. Commun. 1983; 110: 15–22
   PubMed Web of Science ®Google Scholar
• Iversen P. L., Zhu S., Meyer A., Zon G. Cellular Uptake and Subcellular Distribution of Phosphorothioate Oligonucleotides into Cultured Cells. Antisense Res. Dev. 1992; 2: 211–222
   PubMedGoogle Scholar
• Lamond A. I., Sproat B. S. Antisense oligonucleotides made of 2′-O-alkylRNA: Their properties and applications in RNA biochemistry. FEBS Lett. 1993; 325: 123–127
   PubMed Web of Science ®Google Scholar
• Lewis R. N. A. H., McElhaney R. N. The mesomorphic phase behavior of lipid bilayers. The Structure of Biological Membranes, P. Yeagle. CRC Press, Boca Raton 1992; 73–156
   Google Scholar
• Litzinger D. C., Brown J. M., Wala I., Kaufman S. A., Van G. Y., Farrell C. L., Collins D. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim. Biophys. Acta 1996; 1281: 139–149
   PubMed Web of Science ®Google Scholar
• Loke S. L., Stein C. A., Zhang X. H., Mori K., Nakanishi M., Subasinghe C., Cohen J. S., Neckers L. M. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 3474–3478
   PubMed Web of Science ®Google Scholar
• Miele M. E., Bennett C. F., Miller B. E., Welch D. R. Enhanced metastatic ability of TNF-a-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (1CAM-1, CD54) antisense oligonucleotides. Exp. Cell Res. 1994; 214: 231–241
   PubMed Web of Science ®Google Scholar
• Milligan J. F., Matteucci M. D., Martin J. C. Current concepts in antisense drug design. J. Med. Chem. 1993; 36: 1923–1937
   PubMed Web of Science ®Google Scholar
• Monia B. P., Johnston J. F., Ecker D. J., Zounes M., Lima W. F., Freier S. M. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 1992; 267: 19954–19962
   PubMed Web of Science ®Google Scholar
• Monia B. P., Lesnik E. A., Gonzalez C., Lima W. F., McGee D., Guinosso C. J., Kawasaki A. M., Cook P. D., Freier S. M. Evaluation of 2′ modified oligonucleotides containing deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 1993; 268: 14514–14522
   PubMed Web of Science ®Google Scholar
• Monia B. P., Johnston J. F., Geiger T., Muller M., Fabbro D. Antitumor activity of a phosphorothioate oligodeoxy-nucleotide targeted against C-raf kinase. Nature Med. 1995; 2: 668–675
   Google Scholar
• Monia B., Johnston J. F., Sasmor H., Cummins L. L. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras. J. Biol. Chem. 1996; 24: 14533–14540
   Google Scholar
• Nabel E. G., Plautz G., Nabel G. J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249: 1285–1288
   PubMed Web of Science ®Google Scholar
• Perlaky L., Saijo Y., Busch R. K., Bennett C. F., Mirabelli C. K., Crooke S. T., Busch H. Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression. Anti-Cancer Drug Design 1993; 8: 3–14
   PubMedGoogle Scholar
• Roshak A. K., Jackson J. R., McGough K., Chabot-Fletcher M., Mochan E., Marshall L. A. Manipulation of distinct NFkB proteins alters interleukin-1B-induced rheumatoid synovial fibroblast prostaglandin E2 formation. J. Biol. Chem. 1996; 271: 31496–31501
   PubMed Web of Science ®Google Scholar
• Seddon J. M., Harlos K., Marsh D. Metastability and polymorphism in the gel and fluid bilayer phases of dilauroyl-phosphatidylethanolamine. Two crystalline forms in excess water. J. Biol. Chem. 1983; 258: 3850–3857
   PubMed Web of Science ®Google Scholar
• Shoji Y., Akhtar S., Periasamy A., Herman B., Juliano R. L. Mechanism of cellular uptake of modified oligodeoxy-nucleotides containing methylphosphonate linkages. Nucleic Acids Res. 1991; 19: 5543–5550
   PubMed Web of Science ®Google Scholar
• Stein C. A., Cheng Y.-C. Antisense oligonucleotides as therapeutic agents-Is the bullet really magical. Science 1993; 261: 1004–1012
   PubMed Web of Science ®Google Scholar
• Stewart M. J., Plauz G. E., Del Buono L., Yang Z. Y., Xu L., Gao X., Huang L., Nabel E. G., Nabel G. J. Gene transfer in vivo with DNA liposome complexes: safety and toxicity in mice. Gene Therapy 1992; 3: 267–275
   Web of Science ®Google Scholar
• Thierry A. R., Lunardi-Iskandar Y., Bryant J. L., Rabinovich P., Gallo R. C., Mahan L. C. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice. Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 9742–9746
   PubMed Web of Science ®Google Scholar
• Vaughan D. J., Keough K. M. Changes in the phase transitions of phosphatidylethanolamine-and phosphatidylcholine-water dispersions induced by small modifications in the headgroup and backbone regions. FEBS Lett. 1974; 47: 158–165
   PubMed Web of Science ®Google Scholar
• Wagner R. W., Matteucci M. D., Lewis J. G., Gutierrez A. J., Moulds C., Froehler B. C. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 1993; 260: 1510–1513
   PubMed Web of Science ®Google Scholar
• Wu-Pong S., Weiss T. L., Hunt C. A. Antisense c-myc oligonucleotide cellular uptake. Pharm. Res. 1992; 9: 1010–1017
   PubMed Web of Science ®Google Scholar
• Yakubov L. A., Deeva E. A., Zarytova V. F., Ivanova E. M., Ryte A. S., Yurchenko L. V., Vlassov V. V. Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 6454–6458
   PubMed Web of Science ®Google Scholar
• Zelphati O., Szoka F. C. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 11493–11498
   PubMed Web of Science ®Google Scholar
• Zhu N., Liggitt D., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209–211
   PubMed Web of Science ®Google Scholar